Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-03 Purchase |
2025-04-04 07:30 am |
Aprea Therapeutics Inc. | APRE | Gilad Oren President/CEO |
5,500 | $1.8382 | $10,110 | 347,420 (Indirect Direct) |
View |
| 2024-10-18 Sale |
2024-10-25 5:42 pm |
Aprea Therapeutics Inc. | APRE | Duey Marc Director |
6,462 | $4.578 | $29,583 | 234,253 (Indirect Direct) |
View |
| 2024-10-23 Purchase |
2024-10-24 08:30 am |
Aprea Therapeutics Inc. | APRE | Gilad Oren President/CEO |
500 | $3.915 | $1,958 | 335,195 (Indirect Direct) |
View |
| 2024-10-16 Purchase |
2024-10-17 08:30 am |
Aprea Therapeutics Inc. | APRE | Duey Marc Director |
30,000 | $4.39 | $131,700 | 240,715 (Indirect Direct) |
View |
| 2024-10-15 Purchase |
2024-10-16 08:31 am |
Aprea Therapeutics Inc. | APRE | Gilad Oren President/CEO |
250 | $2.9 | $725 | 334,695 (Indirect Direct) |
View |
| 2024-10-14 Purchase |
2024-10-16 08:30 am |
Aprea Therapeutics Inc. | APRE | Duey Marc Director |
190 | $2.58 | $490 | 210,715 (Indirect Direct) |
View |
| 2024-10-11 Purchase |
2024-10-16 08:30 am |
Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr |
50 | $2.4638 | $123 | 19,368 (Direct) |
View |
| 2024-10-11 Purchase |
2024-10-15 08:31 am |
Aprea Therapeutics Inc. | APRE | Seizinger Bernd R. Director |
10,000 | $2.68 | $26,800 | 44,730 (Direct) |
View |
| 2024-10-10 Purchase |
2024-10-15 08:31 am |
Aprea Therapeutics Inc. | APRE | Gilad Oren President/CEO |
1,150 | $2.5835 | $2,971 | 334,445 (Indirect Direct) |
View |
| 2024-10-10 Purchase |
2024-10-15 08:30 am |
Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr |
450 | $2.61 | $1,175 | 19,318 (Direct) |
View |
| 2024-03-13 Purchase |
2024-03-14 8:54 pm |
Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr |
1,010 | $7.29 | $7,363 | 16,513 (Direct) |
View |
| 2024-03-13 Purchase |
2024-03-14 8:53 pm |
Aprea Therapeutics Inc. | APRE | Seizinger Bernd R. Director |
6,860 | $7.29 | $50,009 | 40,545 (Direct) |
View |
| 2024-03-13 Purchase |
2024-03-14 8:52 pm |
Aprea Therapeutics Inc. | APRE | HENNEMAN JOHN B III Director |
6,860 | $7.29 | $50,009 | 14,999 (Direct) |
View |
| 2024-03-13 Purchase |
2024-03-14 8:51 pm |
Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO |
2,000 | $7.29 | $14,580 | 326,770 (Direct) |
View |
| 2023-06-06 Purchase |
2023-06-08 4:34 pm |
Aprea Therapeutics Inc. | APRE | Seizinger Bernd R. Director |
10,097 | $3.6602 | $36,957 | 26,325 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-27 Option Award |
2025-03-31 4:31 pm |
N/A 2035-03-28 |
Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr |
16,825 | $0 | 36,193 (Direct) |
View |
| 2025-03-27 Option Award |
2025-03-31 4:30 pm |
N/A 2035-03-28 |
Aprea Therapeutics Inc. | APRE | Gilad Oren President/CEO |
33,625 | $0 | 368,820 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-21 4:20 pm |
N/A 2034-06-20 |
Aprea Therapeutics Inc. | APRE | Seizinger Bernd R. Director |
5,230 | $0 | 38,915 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-21 4:19 pm |
N/A 2034-06-20 |
Aprea Therapeutics Inc. | APRE | Pamukcu Rifat Director |
5,230 | $0 | 22,694 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-21 4:18 pm |
N/A 2034-06-20 |
Aprea Therapeutics Inc. | APRE | Peters Richard Director |
5,230 | $0 | 6,259 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-21 4:17 pm |
N/A 2034-06-20 |
Aprea Therapeutics Inc. | APRE | HENNEMAN JOHN B III Director |
5,230 | $0 | 13,369 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-21 4:16 pm |
N/A 2034-06-20 |
Aprea Therapeutics Inc. | APRE | Grissinger Michael Director |
5,230 | $0 | 6,029 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-21 4:15 pm |
N/A 2034-06-20 |
Aprea Therapeutics Inc. | APRE | Duey Marc Director |
5,230 | $0 | 214,710 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-02 4:16 pm |
N/A 2034-05-01 |
Aprea Therapeutics Inc. | APRE | Mirza Nadeem Q. Chief Medical Officer |
33,650 | $0 | 33,650 (Direct) |
View |
Ownership |
2024-05-02 4:15 pm |
N/A 2033-02-15 |
Aprea Therapeutics Inc. | APRE | Mirza Nadeem Q. Chief Medical Officer |
0 | $0 | 2,250 (Direct) |
View |
| 2024-03-28 Option Award |
2024-03-28 5:59 pm |
N/A 2024-03-28 |
Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr |
16,825 | $0 | 32,328 (Direct) |
View |
| 2024-03-28 Option Award |
2024-03-28 5:57 pm |
N/A 2024-03-28 |
Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO |
33,625 | $0 | 360,195 (Direct) |
View |
| 2023-08-23 Option Award |
2023-08-24 9:52 pm |
N/A 2033-08-23 |
Aprea Therapeutics Inc. | APRE | Pamukcu Rifat Director |
2,500 | $0 | 19,464 (Direct) |
View |
| 2022-08-23 Conversion |
2023-08-24 9:52 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Pamukcu Rifat Director |
353,265 | $0 | 19,464 (Direct) |
View |
| 2023-08-23 Option Award |
2023-08-24 9:51 pm |
N/A 2033-08-23 |
Aprea Therapeutics Inc. | APRE | Grissinger Michael Director |
2,500 | $0 | 2,799 (Direct) |
View |
| 2023-08-23 Option Award |
2023-08-24 9:51 pm |
N/A 2033-08-23 |
Aprea Therapeutics Inc. | APRE | HENNEMAN JOHN B III Director |
2,500 | $0 | 3,279 (Direct) |
View |
| 2023-08-23 Option Award |
2023-08-24 9:50 pm |
N/A 2033-08-23 |
Aprea Therapeutics Inc. | APRE | Peters Richard Director |
2,500 | $0 | 3,029 (Direct) |
View |
| 2023-08-23 Option Award |
2023-08-24 9:50 pm |
N/A 2033-08-23 |
Aprea Therapeutics Inc. | APRE | Duey Marc Director |
2,500 | $0 | 211,480 (Direct) |
View |
| 2022-08-23 Conversion |
2023-08-24 9:50 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Duey Marc Director |
4,423,430 | $0 | 211,480 (Direct) |
View |
| 2023-08-23 Option Award |
2023-08-24 9:48 pm |
N/A 2033-08-23 |
Aprea Therapeutics Inc. | APRE | Seizinger Bernd R. Director |
2,500 | $0 | 28,825 (Direct) |
View |
| 2023-08-23 Option Award |
2023-08-24 9:47 pm |
N/A 2033-08-23 |
Aprea Therapeutics Inc. | APRE | BIZZARI JEAN-PIERRE Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-05-05 Option Award |
2023-05-08 5:17 pm |
N/A 2033-05-05 |
Aprea Therapeutics Inc. | APRE | Gruia Gabriela Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-03-09 Option Award |
2023-03-13 6:30 pm |
N/A 2033-03-09 |
Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO |
20,000 | $0 | 338,770 (Direct) |
View |
| 2022-08-23 Conversion |
2023-03-13 6:30 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO |
6,649,610 | $0 | 338,770 (Direct) |
View |
| 2023-02-27 Option Award |
2023-02-27 6:37 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr |
1,000 | $5.25 | 14,493 (Direct) |
View |
| 2023-01-30 Option Award |
2023-01-30 5:21 pm |
N/A 2033-01-30 |
Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin. Fin&Acctg. Off |
809,637 | $0 | 809,637 (Direct) |
View |